BeLite Extension Study (Protocol LBS-008-CT08)

BeLite Extension Study (Protocol LBS-008-CT08)

An open label, single-arm, two-year extension study to evaluate the safety and tolerability of Tinlarebant in patients with Stargardt Disease. Participants have already completed the LBS-008-CT02 study protocol.

Clinical trial identifier: ACTRN12623001328662.

Principal investigator: Associate Professor Fred Chen

For more information go to https://www.anzctr.org.au/ACTRN12623001328662.aspx.

To enquire further about this study, please contact the Lions Vision Trials team on (08) 9381 0777, or email lionsvisiontrials@lei.org.au.

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment